Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma

NCT02219178 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: lenalidomide
DRUG: Subcutaneous bortezomib
DRUG: Dexamethasone

Sponsor

Cancer Trials Ireland